SHL Telemedicine Ltd. (SWX:SHLTN)
1.100
+0.030 (2.80%)
Jan 30, 2026, 5:30 PM CET
SHL Telemedicine Revenue
SHL Telemedicine had revenue of $27.92M USD in the half year ending June 30, 2025, a decrease of -3.74%. This brings the company's revenue in the last twelve months to $56.83M, up 1.59% year-over-year. In the year 2024, SHL Telemedicine had annual revenue of $56.78M, down -0.52%.
Revenue (ttm)
$56.83M
Revenue Growth
+1.59%
P/S Ratio
0.90
Revenue / Employee
$108.04K
Employees
526
Market Cap
40.76M CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.78M | -296.00K | -0.52% |
| Dec 31, 2023 | 57.08M | -1.92M | -3.26% |
| Dec 31, 2022 | 59.00M | 9.42M | 18.99% |
| Dec 31, 2021 | 49.58M | 9.42M | 23.45% |
| Dec 31, 2020 | 40.16M | -1.72M | -4.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.36B |
| Novartis AG | 44.95B |
| Lonza Group AG | 6.53B |
| Galderma Group AG | 3.73B |
| Ascom Holding AG | 284.60M |
| Santhera Pharmaceuticals Holding AG | 49.02M |
| BioVersys AG | 1.31M |
| Xlife Sciences AG | 839.38K |
SHL Telemedicine News
- 7 weeks ago - Value Base Ltd. Acquires Significant Stake in SHL Telemedicine Ltd. - GuruFocus
- 1 year ago - DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care - Business Wire
- 1 year ago - SHL Telemedicine GAAP EPS of -$0.24 misses by $0.07, revenue of $27.9M misses by $1.1M - Seeking Alpha
- 1 year ago - SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine - Business Wire
- 1 year ago - SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity - Business Wire
- 1 year ago - SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test - Business Wire
- 1 year ago - SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch - Business Wire
- 1 year ago - SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones - Business Wire